Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 17 04:00PM ET
1.59
Dollar change
+0.08
Percentage change
5.30
%
Index- P/E- EPS (ttm)-3.32 Insider Own12.18% Shs Outstand10.63M Perf Week21.37%
Market Cap16.90M Forward P/E5.89 EPS next Y0.27 Insider Trans-28.51% Shs Float9.34M Perf Month-19.29%
Income-28.94M PEG- EPS next Q-0.33 Inst Own2.50% Short Float8.55% Perf Quarter-14.97%
Sales25.66M P/S0.66 EPS this Y74.27% Inst Trans-70.29% Short Ratio0.31 Perf Half Y-51.38%
Book/sh2.14 P/B0.74 EPS next Y131.52% ROA-61.79% Short Interest0.80M Perf Year-63.95%
Cash/sh0.65 P/C2.44 EPS next 5Y- ROE-88.56% 52W Range1.25 - 6.00 Perf YTD-8.09%
Dividend Est.- P/FCF- EPS past 5Y29.33% ROI-153.37% 52W High-73.50% Beta1.57
Dividend TTM- Quick Ratio1.43 Sales past 5Y50.99% Gross Margin26.17% 52W Low27.20% ATR (14)0.29
Dividend Ex-Date- Current Ratio2.08 EPS Y/Y TTM-27.93% Oper. Margin-76.19% RSI (14)48.36 Volatility26.00% 15.25%
Employees80 Debt/Eq0.05 Sales Y/Y TTM85.24% Profit Margin-112.78% Recom1.00 Target Price9.00
Option/ShortYes / No LT Debt/Eq0.00 EPS Q/Q-163.86% Payout- Rel Volume0.37 Prev Close1.51
Sales Surprise-3.73% EPS Surprise-218.42% Sales Q/Q9.60% EarningsMar 07 BMO Avg Volume2.59M Price1.59
SMA20-3.83% SMA50-7.21% SMA200-42.38% Trades Volume969,313 Change5.30%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Initiated Laidlaw Buy $10
Apr-03-17Downgrade Barclays Equal Weight → Underweight $2.50 → $1.50
Dec-16-16Initiated Oppenheimer Outperform
Jul-15-16Initiated Piper Jaffray Overweight $10
May-22-15Upgrade Canaccord Genuity Hold → Buy $11 → $17
May-08-15Reiterated Barclays Equal Weight $20 → $13
Oct-07-14Initiated Barclays Equal Weight $28
Mar-13-25 09:15AM
Mar-08-25 02:03AM
Mar-07-25 08:00AM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
08:00AM Loading…
Feb-28-25 08:00AM
Feb-19-25 09:10AM
Feb-06-25 08:20AM
Feb-05-25 08:00AM
Feb-04-25 08:00AM
Jan-13-25 08:30AM
07:45AM
Jan-08-25 04:15PM
Jan-07-25 08:05AM
Dec-27-24 05:49PM
08:30AM Loading…
Nov-19-24 08:30AM
Nov-13-24 02:08AM
Nov-12-24 08:00AM
Nov-07-24 04:05PM
Nov-05-24 04:38PM
Nov-04-24 08:00AM
Oct-24-24 04:30PM
Sep-24-24 05:00PM
Sep-12-24 08:30AM
Sep-10-24 08:30AM
Sep-05-24 08:30AM
Sep-04-24 04:15PM
Aug-15-24 08:00AM
Aug-08-24 04:15PM
Jul-02-24 04:30PM
08:30AM Loading…
Jun-26-24 08:30AM
Jun-11-24 10:50AM
Jun-04-24 04:30PM
May-28-24 03:32AM
May-16-24 08:18AM
May-15-24 09:10AM
08:00AM
May-14-24 12:00PM
May-07-24 04:30PM
May-02-24 10:01AM
Apr-26-24 10:19AM
Apr-23-24 09:55AM
Apr-19-24 08:30AM
Apr-12-24 08:30AM
Apr-01-24 04:30PM
Mar-24-24 03:54PM
Mar-22-24 08:30AM
Mar-13-24 11:45AM
Mar-08-24 08:30AM
Mar-01-24 12:00PM
08:45AM
Feb-27-24 09:15AM
08:00AM
Feb-20-24 08:30AM
Jan-29-24 08:00AM
Jan-28-24 08:07PM
Jan-16-24 08:47AM
Jan-12-24 08:30AM
Jan-11-24 05:00PM
Jan-05-24 08:00AM
Jan-04-24 08:00AM
Nov-30-23 04:45PM
Nov-28-23 07:33PM
08:00AM
Nov-20-23 09:20AM
Nov-14-23 08:15AM
08:06AM
Nov-10-23 08:30AM
Nov-07-23 08:00AM
07:40AM
Nov-06-23 08:00AM
Nov-02-23 08:00AM
Oct-31-23 09:25AM
Oct-18-23 08:30AM
Sep-20-23 08:00AM
Sep-06-23 08:00AM
Sep-05-23 08:30AM
Aug-11-23 04:15PM
09:15AM
08:13AM
08:00AM
Aug-09-23 12:46PM
Aug-08-23 04:15PM
Aug-03-23 04:15PM
Jul-28-23 04:15PM
Jul-11-23 05:30PM
07:00AM
Jul-07-23 08:30AM
Jul-05-23 08:30AM
Jun-30-23 04:58PM
Jun-28-23 11:47AM
May-11-23 09:15AM
08:06AM
08:00AM
May-10-23 05:35PM
May-09-23 07:15AM
May-04-23 06:25PM
08:30AM
May-03-23 04:30PM
08:30AM
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lind Global Fund II LP10% OwnerJan 06 '25Sale3.36381,6761,283,1021,049,430Jan 08 05:20 PM
Lind Global Fund II LP10% OwnerJan 07 '25Sale1.94191,434371,907857,996Jan 08 05:20 PM
Richner RandelDirectorDec 13 '24Sale1.684,2857,2140Dec 17 04:08 PM
Turk Joseph E JrDirectorDec 13 '24Buy1.696,00010,14018,516Dec 17 08:55 AM
Swinford MichaelDirectorNov 25 '24Buy2.0321,62243,85865,040Nov 27 08:03 AM
Swinford MichaelDirectorNov 22 '24Buy1.8316,90730,89943,418Nov 26 07:07 AM
Swinford MichaelDirectorNov 20 '24Buy1.8416,47130,23126,511Nov 25 06:16 AM
Jasinski Lawrence JChief Executive OfficerSep 13 '24Sale3.262,6728,700100,637Sep 16 05:34 PM
Jasinski Lawrence JOfficerSep 13 '24Proposed Sale3.272,6728,737Sep 16 06:46 AM
Lynch JeannineVP of Market Access & StrategySep 03 '24Sale3.301,6255,35847,658Sep 04 07:37 PM
Jasinski Lawrence JChief Executive OfficerAug 02 '24Sale3.842,66510,234103,309Aug 06 09:07 AM
Lynch JeannineVP of Market Access & StrategyAug 02 '24Sale3.841,7836,84749,283Aug 06 09:07 AM
Jasinski Lawrence JOfficerAug 02 '24Proposed Sale4.422,66511,782Aug 05 06:20 AM
Lynch JeannineVP of Market Access & StrategyJul 01 '24Sale3.831,8347,01851,066Jul 02 05:02 PM
Jasinski Lawrence JChief Executive OfficerJun 18 '24Sale4.223,46614,617105,974Jun 21 08:47 AM
Lawless Michael AChief Financial OfficerMay 23 '24Buy4.972,0009,9404,150May 28 04:42 PM
Turk Joseph E JrDirectorMay 23 '24Buy5.017,91639,65912,516May 24 08:17 PM
Turk Joseph E JrDirectorMay 22 '24Buy5.01844214,600May 24 08:17 PM
Jasinski Lawrence JChief Executive OfficerMay 21 '24Sale4.911,6207,954109,440May 23 08:24 PM